◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Marvel Biosciences Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2025Jul 31, 2025 FY 2024Jul 31, 2024 FY 2023Jul 31, 2023 FY 2022Jul 31, 2022 FY 2021Jul 31, 2021
Total Revenue 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 --
Cost Of Revenue 547,366 302,023 887,516 1.4M --
Gross Profit -547,366 -302,023 -887,516 -1.4M --
Selling General And Administration 920,805 913,410 1.4M 1.1M --
General And Administrative Expense 920,805 913,410 1.1M 1.1M --
Depreciation And Amortization In Income Statement -- -- 0.00 152.00 185.00
Other Operating Expenses -219,488 56,451 -48,085 52,667 --
Operating Expense 701,317 969,861 1.4M 1.2M --
Operating Income -1.2M -1.3M -2.2M -2.5M --
EBIT -1.9M -1.5M -2.3M -2.6M --
Interest Expense 268,006 113,977 38,422 0.00 --
Interest Expense Non Operating 268,006 113,977 38,422 0.00 --
Interest Income 1,934 0.00 -- 0.00 239.00
Interest Income Non Operating 1,934 0.00 -- 0.00 239.00
Net Interest Income -266,072 -113,977 -38,422 -1,549 --
Other Income Expense -696,713 -264,218 -4,782 -4,311 --
Other Non Operating Income Expenses -600,000 -210,000 -- -- -35,000
Special Income Charges -72,340 0.00 -- 0.00 -1.9M
Restructuring And Mergern Acquisition -- -- -- 0.00 1.9M
Write Off 72,340 0.00 -- -- --
Gain On Sale Of Security -24,373 -54,218 -4,782 -4,311 --
Pretax Income -2.2M -1.7M -2.3M -2.6M --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -2.2M -1.7M -2.3M -2.6M --
Net Income From Continuing Operation Net Minority Interest -2.2M -1.7M -2.3M -2.6M --
Net Income Including Noncontrolling Interests -2.2M -1.7M -2.3M -2.6M --
Net Income Common Stockholders -2.2M -1.7M -2.3M -2.6M --
Net Income -2.2M -1.7M -2.3M -2.6M --
EBITDA -1.9M -1.5M -2.3M -2.6M --
Normalized EBITDA -1.8M -1.5M -2.3M -2.5M --
Reconciled Depreciation -- -- 0.00 152.00 185.00
Basic EPS -0.05 -0.04 -0.06 -0.08 --
Diluted EPS -0.05 -0.04 -0.06 -0.08 --
Basic Average Shares 47.3M 40.0M 39.7M 32.8M --
Diluted Average Shares 47.3M 40.0M 39.7M 32.8M --
Total Unusual Items -96,713 -54,218 -4,782 -4,311 --
Total Unusual Items Excluding Goodwill -96,713 -54,218 -4,782 -4,311 --
Tax Rate For Calcs 0.00 0.00 0.40 0.00 --
Normalized Income -2.1M -1.6M -2.3M -2.5M --
Depreciation Amortization Depletion Income Statement -- -- 0.00 152.00 185.00
Depreciation Income Statement -- -- 0.00 152.00 185.00
Diluted NI Availto Com Stockholders -2.2M -1.7M -2.3M -2.6M --
Net Income Continuous Operations -2.2M -1.7M -2.3M -2.6M --
Net Non Operating Interest Income Expense -266,072 -113,977 -38,422 -1,549 --
Other Gand A 480,713 443,336 415,561 411,920 --
Reconciled Cost Of Revenue 547,366 302,023 887,516 1.4M --
Salaries And Wages 440,092 470,074 680,737 706,380 --
Selling And Marketing Expense -- 74,822 312,456 0.00 --
Total Expenses 1.2M 1.3M 2.2M 2.5M --
Total Other Finance Cost -- -- 3,831 1,549 1,968
Line Item FY 2025Jul 31, 2025 FY 2024Jul 31, 2024 FY 2023Jul 31, 2023 FY 2022Jul 31, 2022 FY 2021Jul 31, 2021
Cash And Cash Equivalents 128,855 345,769 556,622 593,207 --
Cash Cash Equivalents And Short Term Investments 128,855 345,769 556,622 593,207 --
Cash Financial 128,855 345,769 556,622 593,207 --
Receivables 167,549 115,925 81,914 56,438 --
Prepaid Assets 30,311 29,617 33,853 263,896 --
Current Assets 326,715 491,311 672,389 913,541 --
Gross PPE -- -- -- 0.00 1,034
Accumulated Depreciation -- -- -- 0.00 -882.00
Net PPE -- -- -- 0.00 152.00
Total Non Current Assets 0.00 0.00 0.00 0.00 --
Total Assets 326,715 491,311 672,389 913,541 --
Current Debt 2.3M 1.7M -- -- --
Current Debt And Capital Lease Obligation 2.3M 1.7M -- -- --
Accounts Payable 1.5M 1.3M 1.2M 262,095 --
Payables 1.5M 1.3M 1.4M 718,005 --
Payables And Accrued Expenses 2.0M 1.6M 1.4M 718,005 --
Current Accrued Expenses 522,649 259,231 34,411 0.00 --
Current Deferred Revenue -- -- -- 26,217 0.00
Current Liabilities 4.3M 3.3M 1.4M 718,005 --
Long Term Debt -- 1.7M 1.0M -- --
Long Term Debt And Capital Lease Obligation -- 1.7M 1.0M -- --
Total Non Current Liabilities Net Minority Interest 0.00 0.00 1.0M 0.00 --
Total Liabilities Net Minority Interest 4.3M 3.3M 2.4M 718,005 --
Common Stock 8.5M 7.6M 7.1M 6.9M --
Capital Stock 8.5M 7.6M 7.1M 6.9M --
Additional Paid In Capital -- 294,611 202,137 122,022 99,522
Retained Earnings -12.9M -10.7M -9.0M -6.8M --
Gains Losses Not Affecting Retained Earnings 439,673 294,611 -- -- --
Common Stock Equity -4.0M -2.8M -1.7M 195,536 --
Stockholders Equity -4.0M -2.8M -1.7M 195,536 --
Total Equity Gross Minority Interest -4.0M -2.8M -1.7M 195,536 --
Total Capitalization -4.0M -2.8M -720,088 195,536 --
Net Tangible Assets -4.0M -2.8M -1.7M 195,536 --
Tangible Book Value -4.0M -2.8M -1.7M 195,536 --
Working Capital -4.0M -2.8M -720,088 195,536 --
Invested Capital -1.7M -1.1M -720,088 195,536 --
Total Debt 2.3M 1.7M 1.0M -- --
Net Debt 2.2M 1.4M 443,378 -- --
Share Issued 53.0M 44.8M 39.8M 37.1M --
Ordinary Shares Number 53.0M 44.8M 39.8M 37.1M --
Current Deferred Liabilities -- -- -- 26,217 0.00
Dueto Related Parties Current -- -- -- -- 0.00
Interest Payable 286,356 146,356 34,411 0.00 --
Machinery Furniture Equipment -- -- -- 0.00 1,034
Other Current Borrowings 2.3M 1.7M -- -- --
Other Equity Interest -- -- -- -30,000 --
Other Payable -- 112,875 149,626 455,910 110,914
Other Receivables 150,000 -- -- -- --
Taxes Receivable 17,549 115,925 81,914 56,438 --
Line Item FY 2025Jul 31, 2025 FY 2024Jul 31, 2024 FY 2023Jul 31, 2023 FY 2022Jul 31, 2022 FY 2021Jul 31, 2021
Operating Cash Flow -1.2M -1.2M -1.3M -2.2M --
Cash Flow From Continuing Operating Activities -1.2M -1.2M -1.3M -2.2M --
Depreciation And Amortization -- -- 0.00 152.00 185.00
Depreciation Amortization Depletion -- -- 0.00 152.00 185.00
Stock Based Compensation 75,126 75,720 80,115 0.00 --
Change In Working Capital 291,179 184,863 879,039 360,050 --
Change In Receivables -123,964 4,236 -25,476 2,668 --
Change In Payables And Accrued Expense 415,837 214,638 674,472 605,528 --
Other Non Cash Items 622,500 210,000 -- -- 1.8M
Sale Of Business -- -- -- 0.00 381,573
Investing Cash Flow -- -- -- 0.00 381,573
Cash Flow From Continuing Investing Activities -- -- -- 0.00 381,573
Issuance Of Debt 0.00 500,000 1.0M 0.00 --
Net Issuance Payments Of Debt 0.00 500,000 1.0M 0.00 --
Issuance Of Capital Stock 1.0M 500,000 270,000 420,000 --
Net Common Stock Issuance 1.0M 500,000 270,000 420,000 --
Financing Cash Flow 933,409 968,643 1.3M 394,000 --
Cash Flow From Continuing Financing Activities 933,409 968,643 1.3M 394,000 --
Changes In Cash -216,914 -210,853 -36,585 -1.8M --
Beginning Cash Position 345,769 556,622 593,207 2.4M --
End Cash Position 128,855 345,769 556,622 593,207 --
Free Cash Flow -1.2M -1.2M -1.3M -2.2M --
Income Tax Paid Supplemental Data 0.00 0.00 -- -- --
Interest Paid Supplemental Data 0.00 0.00 -- -- --
Asset Impairment Charge 72,340 0.00 -- -- --
Change In Prepaid Assets -694.00 -34,011 230,043 -248,146 --
Common Stock Issuance 1.0M 500,000 270,000 420,000 --
Depreciation -- -- 0.00 152.00 185.00
Long Term Debt Issuance -- 500,000 1.0M 0.00 --
Net Business Purchase And Sale -- -- -- 0.00 381,573
Net Income From Continuing Operations -2.2M -1.7M -2.3M -2.6M --
Net Long Term Debt Issuance -- 500,000 1.0M 0.00 --
Net Other Financing Charges -87,966 -31,357 25,650 -26,000 --
Net Short Term Debt Issuance 0.00 500,000 1.0M 0.00 --
Proceeds From Stock Option Exercised 2,625 0.00 -- 0.00 125,000
Short Term Debt Issuance 0.00 500,000 1.0M 0.00 --
NEWS
Loading news...
TRENDING
Loading...